Parkinson’s disease: Research identifies a potential biomarker
For the first time, a team of researchers has shown a significant increase in the chemokine prokineticin 2 (PK2), a chemokine-like peptide, in the serum of patients with Parkinson's disease. The results of this pilot study conducted by of the Institute...
Parkinson’s disease: Research identifies a potential biomarker